Aurubis (ETR:NDA – Get Rating) has been given a €110.00 ($115.79) target price by stock analysts at Baader Bank in a report released on Tuesday, Borsen Zeitung reports. Baader Bank’s price objective suggests a potential upside of 14.25% from the company’s current price.
Several other equities analysts also recently commented on NDA. Warburg Research set a €97.00 ($102.11) price objective on Aurubis in a research report on Tuesday. Deutsche Bank Aktiengesellschaft set a €90.00 ($94.74) price target on Aurubis in a report on Tuesday, February 8th. Deutsche Bank Rese… set a €95.00 ($100.00) price objective on shares of Aurubis in a report on Thursday, April 14th. Finally, Kepler Capital Markets set a €65.00 ($68.42) target price on shares of Aurubis in a report on Monday, January 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of €89.38 ($94.08).
Aurubis stock traded down €6.37 ($6.71) during mid-day trading on Tuesday, hitting €96.28 ($101.35). The stock had a trading volume of 144,603 shares, compared to its average volume of 324,299. Aurubis has a one year low of €62.20 ($65.47) and a one year high of €116.85 ($123.00). The company has a current ratio of 2.33, a quick ratio of 0.71 and a debt-to-equity ratio of 11.38. The firm has a market capitalization of $4.20 billion and a P/E ratio of 5.68. The firm’s 50 day moving average is €107.70 and its 200 day moving average is €94.69.
Aurubis AG processes metal concentrates and recycling materials in Germany. The company processes scrap metals, organic and inorganic metalbearing recycling raw materials, and industrial residues. It also offers wire rods and specialty wires, shapes, bars and profiles, industrial rolled products, and architectural rolled products.
Featured Stories
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Follow The Money To Cigna
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.
